USANA Health Sciences Inc. - Form 8-K Summary
Business Context and Reporting Period
USANA Health Sciences, Inc. (USNA) filed a Current Report on Form 8-K on August 4, 2026. The filing announces the financial results for the second quarter ended July 4, 2026. The Company is incorporated in Utah and its common stock trades on the New York Stock Exchange.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release and management commentary. It does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained in the attached exhibits (99.1 and 99.2) which are not included in the source text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the attached press release and management commentary for comparative analysis.
Guidance, Outlook, and Management Commentary
- Management Commentary: The Company announced it will post a document titled "Management Commentary" on its corporate website.
- Conference Call: Executives will hold a conference call with investors, broadcast via the World Wide Web and telephone. The call will feature brief remarks followed by a question and answer session.
- Disclosure Status: The information in this report is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. It is not intended to be incorporated by reference into registration statements.
Investor Verification Checklist
- Verify the specific revenue and net income figures for the quarter ended July 4, 2026, in the attached press release (Exhibit 99.1).
- Review the "Management Commentary" (Exhibit 99.2) for details on operational performance and strategic outlook.
- Confirm the date and time of the investor conference call to access management's direct remarks.
- Check the Company's website (www.usana.com) for the posted exhibits and additional financial data.